Cargando…

Research Audit on Clinical Utility of Dimensional Disruptive Mood and Behavior Psychopathologies in Child and Adolescent Psychiatry Practice

To investigate the utility of dimensional psychopathologies of disruptive mood and behavior disorders (DBDs) by applying latent profile analysis (LPA) for characterization of youth referred to the tertiary outpatient clinic of child and adolescent psychiatry clinic and pharmacological treatment choi...

Descripción completa

Detalles Bibliográficos
Autores principales: Suk, Ji-Woo, Poppert Cordts, Katrina M., Garvey, William, Lerdahl, Arica, Soltis-Vaughan, Brigette, Bohn, Alexandra, Edwards, Ryan, Blair, Robert James, Hwang, Soonjo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020472/
https://www.ncbi.nlm.nih.gov/pubmed/35463527
http://dx.doi.org/10.3389/fpsyt.2022.742148
_version_ 1784689538436694016
author Suk, Ji-Woo
Poppert Cordts, Katrina M.
Garvey, William
Lerdahl, Arica
Soltis-Vaughan, Brigette
Bohn, Alexandra
Edwards, Ryan
Blair, Robert James
Hwang, Soonjo
author_facet Suk, Ji-Woo
Poppert Cordts, Katrina M.
Garvey, William
Lerdahl, Arica
Soltis-Vaughan, Brigette
Bohn, Alexandra
Edwards, Ryan
Blair, Robert James
Hwang, Soonjo
author_sort Suk, Ji-Woo
collection PubMed
description To investigate the utility of dimensional psychopathologies of disruptive mood and behavior disorders (DBDs) by applying latent profile analysis (LPA) for characterization of youth referred to the tertiary outpatient clinic of child and adolescent psychiatry clinic and pharmacological treatment choices. One hundred fifty-eight children and adolescents with significant DBDs symptoms participated. Core dimensional psychopathologies of DBDs (irritability, callous-unemotional trait, and reactive-proactive aggressive behavior), DSM diagnoses, prescribed medications, and behavioral and emotional problems (Child Behavior Checklist, CBCL) were measured at baseline (clinic intake) and at 3-month follow-up. Latent Profile Analysis (LPA) was applied to characterize the study population based on the levels and interrelations among the core dimensional DBDs psychopathologies. Following LPA, the differences in clinical and treatment features between the latent classes were analyzed. LPA revealed two latent classes based on severity of DBDs symptoms. Class 1 (the moderate group) was characterized by relatively low scores on all trans-diagnostic indicators, whereas class 2 (the severe/critical group) showed higher levels of the dimensional psychopathologies and the majority of CBCL subscales. In addition, the severe/critical group was more often prescribed antipsychotic medications, and also experienced more frequent medication changes (addition, increasing the dose, and trial of different medications). Our findings suggested that application of LPA to a cluster of dimensional DBDs psychopathologies may provide valuable characterization of the youths referred to a tertiary outpatient child and adolescent psychiatric clinic, and offer insight into the providers' decision making on psychotropic medications, by overall severity of these psychopathologies rather than by single categorical diagnosis or single externalizing psychopathology.
format Online
Article
Text
id pubmed-9020472
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90204722022-04-21 Research Audit on Clinical Utility of Dimensional Disruptive Mood and Behavior Psychopathologies in Child and Adolescent Psychiatry Practice Suk, Ji-Woo Poppert Cordts, Katrina M. Garvey, William Lerdahl, Arica Soltis-Vaughan, Brigette Bohn, Alexandra Edwards, Ryan Blair, Robert James Hwang, Soonjo Front Psychiatry Psychiatry To investigate the utility of dimensional psychopathologies of disruptive mood and behavior disorders (DBDs) by applying latent profile analysis (LPA) for characterization of youth referred to the tertiary outpatient clinic of child and adolescent psychiatry clinic and pharmacological treatment choices. One hundred fifty-eight children and adolescents with significant DBDs symptoms participated. Core dimensional psychopathologies of DBDs (irritability, callous-unemotional trait, and reactive-proactive aggressive behavior), DSM diagnoses, prescribed medications, and behavioral and emotional problems (Child Behavior Checklist, CBCL) were measured at baseline (clinic intake) and at 3-month follow-up. Latent Profile Analysis (LPA) was applied to characterize the study population based on the levels and interrelations among the core dimensional DBDs psychopathologies. Following LPA, the differences in clinical and treatment features between the latent classes were analyzed. LPA revealed two latent classes based on severity of DBDs symptoms. Class 1 (the moderate group) was characterized by relatively low scores on all trans-diagnostic indicators, whereas class 2 (the severe/critical group) showed higher levels of the dimensional psychopathologies and the majority of CBCL subscales. In addition, the severe/critical group was more often prescribed antipsychotic medications, and also experienced more frequent medication changes (addition, increasing the dose, and trial of different medications). Our findings suggested that application of LPA to a cluster of dimensional DBDs psychopathologies may provide valuable characterization of the youths referred to a tertiary outpatient child and adolescent psychiatric clinic, and offer insight into the providers' decision making on psychotropic medications, by overall severity of these psychopathologies rather than by single categorical diagnosis or single externalizing psychopathology. Frontiers Media S.A. 2022-04-06 /pmc/articles/PMC9020472/ /pubmed/35463527 http://dx.doi.org/10.3389/fpsyt.2022.742148 Text en Copyright © 2022 Suk, Poppert Cordts, Garvey, Lerdahl, Soltis-Vaughan, Bohn, Edwards, Blair and Hwang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Suk, Ji-Woo
Poppert Cordts, Katrina M.
Garvey, William
Lerdahl, Arica
Soltis-Vaughan, Brigette
Bohn, Alexandra
Edwards, Ryan
Blair, Robert James
Hwang, Soonjo
Research Audit on Clinical Utility of Dimensional Disruptive Mood and Behavior Psychopathologies in Child and Adolescent Psychiatry Practice
title Research Audit on Clinical Utility of Dimensional Disruptive Mood and Behavior Psychopathologies in Child and Adolescent Psychiatry Practice
title_full Research Audit on Clinical Utility of Dimensional Disruptive Mood and Behavior Psychopathologies in Child and Adolescent Psychiatry Practice
title_fullStr Research Audit on Clinical Utility of Dimensional Disruptive Mood and Behavior Psychopathologies in Child and Adolescent Psychiatry Practice
title_full_unstemmed Research Audit on Clinical Utility of Dimensional Disruptive Mood and Behavior Psychopathologies in Child and Adolescent Psychiatry Practice
title_short Research Audit on Clinical Utility of Dimensional Disruptive Mood and Behavior Psychopathologies in Child and Adolescent Psychiatry Practice
title_sort research audit on clinical utility of dimensional disruptive mood and behavior psychopathologies in child and adolescent psychiatry practice
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020472/
https://www.ncbi.nlm.nih.gov/pubmed/35463527
http://dx.doi.org/10.3389/fpsyt.2022.742148
work_keys_str_mv AT sukjiwoo researchauditonclinicalutilityofdimensionaldisruptivemoodandbehaviorpsychopathologiesinchildandadolescentpsychiatrypractice
AT poppertcordtskatrinam researchauditonclinicalutilityofdimensionaldisruptivemoodandbehaviorpsychopathologiesinchildandadolescentpsychiatrypractice
AT garveywilliam researchauditonclinicalutilityofdimensionaldisruptivemoodandbehaviorpsychopathologiesinchildandadolescentpsychiatrypractice
AT lerdahlarica researchauditonclinicalutilityofdimensionaldisruptivemoodandbehaviorpsychopathologiesinchildandadolescentpsychiatrypractice
AT soltisvaughanbrigette researchauditonclinicalutilityofdimensionaldisruptivemoodandbehaviorpsychopathologiesinchildandadolescentpsychiatrypractice
AT bohnalexandra researchauditonclinicalutilityofdimensionaldisruptivemoodandbehaviorpsychopathologiesinchildandadolescentpsychiatrypractice
AT edwardsryan researchauditonclinicalutilityofdimensionaldisruptivemoodandbehaviorpsychopathologiesinchildandadolescentpsychiatrypractice
AT blairrobertjames researchauditonclinicalutilityofdimensionaldisruptivemoodandbehaviorpsychopathologiesinchildandadolescentpsychiatrypractice
AT hwangsoonjo researchauditonclinicalutilityofdimensionaldisruptivemoodandbehaviorpsychopathologiesinchildandadolescentpsychiatrypractice